Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
affective disorders
agitation
agranulocytosis
akathisia
akinetic mute
algorithm
alien hand syndrome
alpha-synuclein
Alzheimer's disease
amantadine
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinesterase
antidepressant
anxiety
aphasia
aphasia, progressive, primary
aphonia
applause sign
apraxia
apraxia of eyelid opening
aprazolam
aripiprazole
arm swing, reduced
ataxia
ataxia, cerebellar
ataxia, progressive
atypical
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autonomic cardiovascular reflexes
autonomic dysfunction
basal ganglia, infarction
basal ganglia, lesion, bilateral
behavioral disorder
benzodiazepine
bicycle sign
biologic markers
black box warning
blepharospasm
blinking
blinking, reduced
bradykinesia
bradykinesia, facial
bradyphrenia
burning mouth
burning paresthesia
burst suppression pattern, electroencephalogram
buspirone
cachexia
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortical atrophy
cerebral infarction, subcortical
cerebrovascular accident
cerebrovascular disease
chromosome 19
cingulate island sign
Clinical Pathologic Conference(C.P.C.)
clonazepam
clozapine
coat-hanger pain
cogentin
cognition
cogwheel rigidty
complications
compulsivity
cortical-basal ganglionic degeneration
cycling
degenerative diseases of CNS
delay in diagnosis
delirium
delusion
dementia
dementia, familial
dementia, frontotemporal
dementia, subcortical
deprenyl
depression
desipramine
diagnostic criteria
differential diagnosis
diplopia
dizziness
dopamine
dopamine agonist
dopamine antagonist
downward gaze
drug induced neurologic disorders
drug interactions
dyskinesia
dyskinesia, drug induced
dysphagia
dystonia
dystonia, drug induced
dystonia, face
dystonia, focal
dystonic reaction, acute
efficacy
electroconvulsive therapy
electron microscopy
emergencies, neurologic
emergency room
encephalitis, autoimmune
enzyme inhibition
epidemiology of neurology
erectile dysfunction
ergotamine
evidence-based research
extrapyramidal movement disorder, progressive
eye movement, disorders of
facial appearance, abnormal
facial expression abnormality
falling
familial
fever
fine motor function, impaired
fluoxetine
frontal behavioral spatial syndrome
gait disorder
gait, apraxic
gammaglobulin therapy, intravenous
gaze palsy
gaze palsy, supranuclear
gaze palsy, vertical
gene mutation
gene therapy
genetic neurologic disorders
genetic testing
glutamic acid decarboxylase, antibody
hallucination
haloperidol
hand weakness
hands, fisted
head injury
hemidystonia
hemiparesis
heralding manifestation
hummingbird sign
hyperreflexia
hypertension
hypophonia
hyposmia
hypotension, neurologic causes of
hypotension, systemic
hypothyroidism
iatrogenic neurologic disorders
ideomotor apraxia
imbalance
imbalance, postural
immunomodulation
inclusion bodies
inclusion bodies, eosinophilic cytoplasmic
intracranial hypotension
jealousy
L-dopa
L-dopa, controlled release
L-dopa, drug interactions with and side effects of
leg spasms, painful
leucine rich glioma inactivated 1 antibodies
leukemia, neurologic findings assoc.with
leukoencephalopathy
level of consciousness, decreased
Lewy body
Lewy body disease, diffuse
life expectancy
lorazepam
marche a petits pas
masked facies
memory, impairment of
meningitis
microangiopathy, brain
midbrain
midbrain, atrophy
mimics
Mini Mental Status Examination
misdiagnosis
morning glory sign
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
MRI, abnormal
MRI, negative
multiple sclerosis
multiple sclerosis, treatment of
multiple system atrophy
muscle cramp
muscle spasm
myelomeningocele
myoclonus
neck pain
neurofilament light chain protein
neurofilaments
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications
neurologic disease, diagnoses of
neurologic disease, tempo
neurologic signs
neurologic symptoms
neuroophthalmology
neuropathology
neuropathology, brain
nortriptyline
obsessive-compulsive disorder
olanzapine
old age, neurology of
ondansetron
ophthalmoplegia
ophthalmoplegia, total
orthostatic hypotension
Othello syndrome
pain
pain, genital
pain, mouth
pallidotomy
panic attacks
paranoia
Parkinson disease
Parkinson disease, akinetic form
Parkinson disease, arteriosclerotic
Parkinson disease, asymmetric onset
Parkinson disease, atypical
Parkinson disease, axial symptoms
Parkinson disease, benign tremulous
Parkinson disease, complications, late
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug induced
Parkinson disease, duration
Parkinson disease, dystonia with
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, exacerbation
Parkinson disease, familial
Parkinson disease, fluctuations in
Parkinson disease, heterogeneity of
Parkinson disease, intractable
Parkinson disease, L-dopa nonresponsive
Parkinson disease, misdiagnosis
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, rapid onset
Parkinson disease, rapid progression
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, transient
Parkinson disease, treatment of
Parkinson disease, tremor, absence of
Parkinson disease, unilateral
Parkinson disease, wearing off
Parkinson disease, young onset
Parkinsonism hyperpyrexia syndrome
Parkinsonism multiple-system atrophy
Parkinsonism syndrome
Parkinsonism, freezing phenomena in
Parkinsonism-dementia complex
patient information and support
penguin silhouette sign
personality change
phenothiazine
phenothiazine, dyskinesia associated with
postural abnormality
practice guidelines
preclinical
primary intracranial hypotension
prognosis
progressive neurologic disorder
progressive supranuclear palsy
pseudobulbar palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
psychotic behavior
pull test
pyramidal tract dysfunction
quetiapine
rapid onset dystonia parkinsonism
rapidly progressing neurologic illness
reading disorder, acquired
reading problem, causes of
Red flags
remote effect of cancer on the nervous system
retrocollis
review article
rigidity
rigidity, axial
risk factors
risperidone
Romberg's sign
saccadic eye movements
saccadic eye movements, abnormal
safety
sagging of the brain
salivation, excessive
seizure
selective serotonin reuptake inhibitors
sequencing difficulty
serotonin syndrome
shoulder, pain in
sinemet
single photon emission computed tomography
skin, biopsy
sleep pathology and physiology
small vessel disease
SNCA duplication
speech disorder
standing difficulty
stare
stereotaxic surgery
stiff man syndrome
stimulation, deep brain
swallow evaluation
syncope
synucleinopathy
systemic illness
tandem gait, ataxic
tardive dyskinesia
tau protein
tauopathy
temporal lobe, lesion
temporal lobe, lesion, bilateral
thalamotomy
trazodone
treatment of neurologic disorder
tremor
tremor, intention
tremor, resting
tremor, surgical treatment of
tremor, treatment of
tricyclic antidepressant
urinary incontinence
vision, blurred
visual symptoms
walking, difficulty with
weight loss
wheelchair
wide based gait
Showing articles 750 to 800 of 1482 << Previous Next >>

A 60-Year-Old Man with Parkinson's Disease
JAMA 275:716-722, Olanow,C.W., 1996

Lewy Body Disease and Dementia
Arch Int Med 156:487-493, Kalra,S.,et al, 1996

Consensus Statement on the Definition of Orthostatic Hypotension, Pure Autonomic Failure, and Multiple System Atrophy
Neurol 46:1470, Schatz,I.J.,et al, 1996

Natural History of Progressive Supranuclear Palsy & Clin Predictors of Survival:A Clinicopath Study
JNNP 61:615-620, Litvan,I.,et al, 1996

Effect of Thalamic Stimulation on Gait in Parkinson Disease
Arch Neurol 53:898-903, Defebvre,L.,et al, 1996

Manganese Toxicity in Children Receiving Long-Term Parental Nutrition
Lancet 347:1218-1221, Fell,J.M.E.,et al, 1996

Frequency of Dementia in Parkinson Disease
Arch Neurol 42:428-431, Aarsland,D.,et al, 1996

Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Survival & Prolif of Nonneural Tissu, with Obstr of Cereb Ventric, In Parkinson Pt Trt with Fetal Allografts
Neurol 46:1219-1225, Folkerth,R.D.&Durso,R., 1996

Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Gamma Knife Pallidotomy in Advanced Parkinson's Disease
Ann Neurol 39:535-538, Friedman,J.H.,et al, 1996

Diet and Parkinson's Diseae I:A Possible Role for the Past Intake of Specific Foods and Food Groups
Neurol 47:636-643, Hellenbrand,W.,et al, 1996

Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996

Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996

Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996

Movement Disorders Associated with the Serotonin Selective Reuptake Inhibitors
J Clin Psychiatry 57:449-454, Leo,R.J., 1996

Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995

Extrapyramidal Symptoms in a BMT Recipient with Hyperintense Basal Ganglia and Elevated Manganese
Bone Marrow Transplantation 15:989-992, Fredstrom,S.,et al, 1995

Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995

Disabling Parkinsonism Due to Lithium: A Case Report
J Geriatr Psychiatry Neurol 8:118-119, Holroyd,S. & Smith,D., 1995

The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995

Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995

MRI In Patients with Suspected Vascular Parkinsonism
Neurol 45:2183-2188, Jijlmans,J.C.M.,et al, 1995

Neurological Sequelae of Cyanide Intoxication-The Patterns of Clinical MRI & Pet Findings
Ann Neurol 38:825-828, Rosenow,F.,et al, 1995

Occult Intracranial Tumours Masquerading as Early Onset Anorexia Nervosa
BMJ 311:1359-1360, DeVile,C.J.,et al, 1995

Comparison of Therapeutic Effects & Mortality Data of Levodopa & Levodopa with Selegiline in Pts with Early, Mild Parkinson's
BMJ 311:1602-1607, 15831995., Lee,A.J.,et al, 1995

Occurrence of Different Cancers in Patients with Parkinson's Disease
BMJ 310:1500-1501, Moller,H.,et al, 1995

Neuropath Evid of Graft Survival & Striatal Reinnerva after Transpl of Fetal Mesencephalic Tissue in Parkinson's Dis
NEJM 332:1118-1124, 11631995., Kordower,J.H.,et al, 1995

Bilateral Fetal Nigral Transplantation Into the Postcommissural Putamen in Parkinson's Disease
Ann Neurol 38:379-388, Freemen,T.B.,et al, 1995

Stereotactic Ventral Pallidotomy for Parkinson's Disease
Neurol 45:753-761, Dogali,M.,et al, 1995

Electroconvulsive Therapy for the Physical Signs of Parkinson's Disease Without Depressive Disorder
JNNP 58:641-642, Pridmore,S.,et al, 1995

Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995

Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995

Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995

Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995

Dopa-Responsive parkinsonism Phenotype of Machado-Jospeh Disease:Confirmation of 14q CAG Expansion
Ann Neurol 48:684-687, Tuite,P.J.,et al, 1995

Different of Multi Syst Atrophy from Idiopathic Parkinson's Disease Using Proton MR Spectroscopy
Ann Neurol 37:204-210, Davie,C.A.,et al, 1995

Comparative Study of Selegiline Plus L-Dopa-Carbidopa VS L-Dopa-Carbidopa Alone in Trtm of Parkinson's Disease
Ann Neurol 37:95-98, Brannan,T.&Yahr,M.D., 1995

Clinicopathological Study of 35 Cases of Multiple System Atrophy
JNNP 58:160-166, Wenning,G.K.,et al, 1995

Effect on Parkinsonian Signs and Symptoms of Bilateral Subthalamic Nucleus Stimulation
Lancet 345:91-95, Limousin,P.,et al, 1995

Parkinsonism-Recognition and Differential Diagnosis
BMJ 310:447-452, Quinn,N., 1995

Neuroleptic Drug Exposure and Treatment of Parkinsonism in the Elderly:A Case-Control Study
Am J Med 99:48-54, Avorn,J.,et al, 1995

Resperidone in Gilles de la Tourette Syndrome
Neurol 45:1419, Shulman,L.M.,et al, 1995

Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995

Exacerbation of Idiopathic Parkinson's Disease by Naproxen
BMJ 311:422, Shaunak,S.,et al, 1995

Encephalopathy with Parkinsonian Features in Children Following Bone Marrow Transplantations and High-Dose Amphotericin B
Ann Neurol 37:810-814, Mott,S.H.,et al, 1995

Dopamine, Dystonia, and the Deficient Co-Factor
Lancet 345:1130, Williams,A.C., 1995

Kindreds of Dominantly Inherited Parkinson's Disease:Keys to the Riddle
Ann Neurol 38:355-356, Duvoisin,R.C.&Golbe,L.I., 1995



Showing articles 750 to 800 of 1482 << Previous Next >>